CFTR Modulation Research funded by CFF
CFTR Modulation Research funded by CFF
Current News and Events
Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF Patients
Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF Patients
Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by Antibiotics
Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by Antibiotics
ProQR’s Inhaled RNA Therapy Improves CF Symptoms in Phase 1 Clinical Trial
ProQR’s Inhaled RNA Therapy Improves CF Symptoms in Phase 1 Clinical Trial
CF Patient, Recovering from Double Transplant, Inspires ‘Lunges4Lungs’ Fundraiser
CF Patient, Recovering from Double Transplant, Inspires ‘Lunges4Lungs’ Fundraiser
Vizient Awards Alcresta Contract for Relizorb, Which Helps CF Patients Digest Healthy Fats
Vizient Awards Alcresta Contract for Relizorb, Which Helps CF Patients Digest Healthy Fats
What’s Next for the CF Community and Health Care Reform
What’s Next for the CF Community and Health Care Reform